Drug Design Group, Progen Pharmaceuticals Ltd, Brisbane QLD 4076, Australia.
Molecules. 2012 Aug 15;17(8):9790-802. doi: 10.3390/molecules17089790.
A 6-deoxy-α-L-talopyranoside acceptor was readily prepared from methyl α-L-rhamnopyranoside and glycosylated with thiogalactoside donors using NIS/TfOH as the promoter to give good yields of the desired a-linked disaccharide (69-90%). Glycosylation with a 2-azido-2-deoxy-D-glucosyl trichloroacetimidate donor was not completely stereoselective (α:β = 6:1), but the desired a-linked disaccharide could be isolated in good overall yield (60%) following conversion into its corresponding tribenzoate derivative. The disaccharides were designed to mimic the heparan sulfate (HS) disaccharide GlcN(2S,6S)-IdoA(2S). However, the intermediates readily derived from these disaccharides were not stable to the sulfonation/deacylation conditions required for their conversion into the target HS mimetics.
从甲基 α-L-鼠李吡喃糖苷出发,很容易制备出 6-去氧-α-L-塔洛吡喃糖苷受体,并使用 NIS/TfOH 作为促进剂,用硫代半乳糖苷供体进行糖基化,以获得所需的 α-连接二糖的良好收率(69-90%)。用 2-叠氮-2-脱氧-D-葡萄糖基三氯乙酰亚胺苷供体进行糖基化时,立体选择性不是完全的(α:β=6:1),但在转化为相应的三苯甲酯衍生物后,所需的 α-连接二糖可以以良好的总收率(60%)分离出来。这些二糖旨在模拟肝素硫酸盐(HS)二糖 GlcN(2S,6S)-IdoA(2S)。然而,这些二糖的中间体很容易在转化为目标 HS 类似物所需的磺化/脱酰基条件下不稳定。